PharmaBlock CMC Lifecycle Strategy Forum: Smarter Decisions Across the Drug Development Lifecycleprnewswire·Nov 9, 2026 at 08:31 AM300725-5.59%
10:57 ETPharmaBlock impulsa la química verde en la fabricación farmacéutica sostenibleprnewswire·Jul 20, 2026 at 02:58 PM300725-5.59%NVS-0.67%
PharmaBlock's First Peptide GMP Pilot-scale Plant at PharmaBlock Zhejiang Site Now OperationalPR Newswire·Jun 4, 2026 at 12:21 PM300725-5.59%
PHARMABLOCK shareholder Zhou Quan plans to reduce holdings by no more than 2.3296 million sharesZhitong·Sep 18, 2025 at 11:19 AM300725-5.59%
Xinjiang Communications Construction Group convertible bonds "JiaoJian Convertible Bonds" will cease tradingZhitong·Sep 17, 2025 at 04:21 AM002941-2.78%300725-5.59%
Zhejiang Merchants Securities: The growth trend of the CXO sector in 25H1 continues to improve, and the construction projects remain at a high levelZhitong·Sep 11, 2025 at 06:19 AM300347-3.83%03347-4.44%
PHARMABLOCK: PHARMABLOCK convertible bonds are about to be redeemed, reminding investors to convert their shares in a timely mannerZhitong·Sep 10, 2025 at 08:40 AM300725-5.59%
PHARMABLOCK reminds about the implementation of the redemption of PHARMABLOCK convertible bonds and the related trading suspensionZhitong·Sep 9, 2025 at 08:39 AM300725-5.59%
PHARMABLOCK announces the fourteenth notice of early redemption for "PHARMABLOCK Convertible Bonds"Zhitong·Sep 3, 2025 at 08:26 AM300725-5.59%
PHARMABLOCK released the fifth reminder announcement for the early redemption of PHARMABLOCK convertible bondsZhitong·Aug 21, 2025 at 07:51 AM300725-5.59%
PHARMABLOCK has systematically laid out AI applications in multiple business areasZhitong·Aug 11, 2025 at 07:27 AM300725-5.59%
PHARMABLOCK released its performance for the first half of the year, with a net profit attributable to the parent company of 72.4981 million yuan, a decrease of 26.54%Zhitong·Aug 7, 2025 at 10:31 AM300725-5.59%